Device-detected atrial fibrillation and risk for stroke: An analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)

European Heart Journal

Volumn 35, Issue 8, 2014, Pages 508-516

  Boriani, Giuseppe ^a   Glotzer, Taya V ^b   Santini, Massimo ^c   West, Teena M ^d   De Melis, Mirko ^d   Sepsi, Milan ^e   Gasparini, Maurizio ^f   Lewalter, Thorsten ^g   Camm, John A ^h   Singer, Daniel E ⁱ  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g Isarklinikum Munich   (Germany)

^h ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anticoagulation; Atrial fibrillation; Implantable defibrillator; Pacemaker; Stroke

Indexed keywords

ANTICOAGULATION; ATRIAL FIBRILLATION; IMPLANTABLE DEFIBRILLATOR; PACEMAKER; STROKE;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; COST OF ILLNESS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84894531440     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht491     Document Type: Article

References (23)

1. Kirchhof P, LipGY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U,Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012;14:8-27.
2. Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012;110:270-276.
3. Fang MC, Go AS, Chang Y, Borowsky L, Pomernacki NK, Singer DE. Comparison of risk stratification schemes to predict thromboembolismin people with non-valvular atrial fibrillation. J Am Coll Cardiol 2008;51:810-815.
4. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA. Atrial high rate episodes detected by pacemaker diagnostics predicts death and stroke. Circulation 2003; 107:1614-1619.
5. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-1920.
6. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, BorianiG. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009;20:241-248.
7. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. TheTRENDSStudy. Circ Arrhythmia Electrophysiol 2009;2:474-480.
8. Boriani G, Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Ricci R, Biffi M, De Santo T, Corbucci G, Lip GY. Improving stroke risk stratification using the CHADS2 and CHA2DS2VASc risk scores in paroxysmal atrial fibrillation patients by continuous arrhythmia burden monitoring. Stroke 2011;42:1768-1770.
9. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Turov A, Shirokova N, Karaskov A. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study. Circ Arrhythm Electrophysiol 2011;4:823-831.
10. Santini M, Gasparini M, Landolina M, Lunati M, Proclemer A, Padeletti L, Catanzariti D, Molon G, Botto GL, La Rocca L, Grammatico A, Boriani G. Devicedetected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol 2011;57:167-172.
11. Welles CC, Whooley MA, Na B, Ganz P, Schiller NB, Turakhia MP. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study. Am Heart J 2011;162:555-561.
12. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 2004;27:983-992.
13. Healey JS, Connolly SJ, Gold MR, IsraelCW, VanGelder IC, Capucci A, LauCP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129.
14. Allison PD. Survival Analysis Using the SAS: A Practical Guide. 1st ed. Gary, NC: SAS Institute Inc., 1995.
15. Lamas G.Howmuchatrial fibrillation is toomuchatrial fibrillation?NEngl JMed2012; 366:178-180.
16. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, Pürerfellner H. Performance of anewleadless implantable cardiacmonitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Circ Arrhythm Electrophysiol 2010;3:141-147.
17. LipGY. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why? Eur Heart J 2013;34:1041-1049.
18. BorianiG, Cervi E, Diemberger I, Martignani C, Biffi M. Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. Chest 2011;140: 843-845.
19. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-2747.
20. Boriani G, Santini M, Lunati M, Gasparini M, Proclemer A, Landolina M, Padeletti L, Botto GL, Capucci A, Bianchi S, Biffi M, Ricci RP, Vimercati M, Grammatico A, Lip GY. Improving thromboprophylaxis using atrial fibrillation diagnostic capabilities in implantable cardioverter-defibrillators: The Multicentre Italian ANGELS of AF Project. Circ Cardiovasc Qual Outcomes 2012;5: 182-188.
21. Gage BF,WatermanAD, ShannonW, Boechler M, RichMW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
22. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, Khatri P, Adeoye O, Ferioli S, Broderick JP, Kissela BM. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke 2010;41:1326-1331.
23. Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol 2012;27:287-295.